Compare Aehr Test Systems (AEHR) vs Freeport-McMoRan Inc (FCX) Price & Performance

AEHR Test Systems stock surged 10.28% to $129.23, extending its strong momentum with a bullish technical outlook. The company reported three consecutive earnings beats and secured a significant $22 million AI processor order, driving investor optimism. Despite negative profitability metrics, AEHR's record $100.6 million backlog and expanding AI/silicon photonics business support growth expectations. Technical indicators show strong bullish momentum with support at $125 and resistance at $133.

AEHR presents a high-risk, high-reward opportunity with strong AI-driven growth potential but faces valuation concerns at 79x sales. The stock's 72% monthly gain reflects optimism about wafer-level burn-in demand, though negative margins and insider selling warrant caution. Upside depends on converting backlog to profitable revenue while managing premium valuation pressures.

FCX trades at $66.83, down 2.98% on the day, but maintains a bullish technical trend with strong analyst support. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $0.72 EPS. Revenue remains stable around $25.9B, while net income margin improved to 11.38% in 2026. Recent news highlights operational challenges like lower copper volumes but also growth initiatives at Grasberg and Bagdad.

The outlook is positive with a consensus price target of $73.85, implying ~10% upside. Key opportunities include exposure to high copper prices and expansion projects, while risks involve production volatility, cost pressures, and reliance on commodity cycles. The stock's valuation appears elevated with a P/E of 33.93, requiring sustained earnings growth to justify further gains.